ZA200808845B - Novel DNA sequences, vectors and proteins of Avian Influenza hemagglutinin - Google Patents

Novel DNA sequences, vectors and proteins of Avian Influenza hemagglutinin

Info

Publication number
ZA200808845B
ZA200808845B ZA200808845A ZA200808845A ZA200808845B ZA 200808845 B ZA200808845 B ZA 200808845B ZA 200808845 A ZA200808845 A ZA 200808845A ZA 200808845 A ZA200808845 A ZA 200808845A ZA 200808845 B ZA200808845 B ZA 200808845B
Authority
ZA
South Africa
Prior art keywords
vectors
proteins
dna sequences
avian influenza
influenza hemagglutinin
Prior art date
Application number
ZA200808845A
Other languages
English (en)
Inventor
Henry Matthew
Ignacio M Larrinua
Sean M Russell
Original Assignee
Dow Agrosciences Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Agrosciences Llc filed Critical Dow Agrosciences Llc
Publication of ZA200808845B publication Critical patent/ZA200808845B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/11—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/517—Plant cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
ZA200808845A 2006-06-16 2008-10-16 Novel DNA sequences, vectors and proteins of Avian Influenza hemagglutinin ZA200808845B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81424106P 2006-06-16 2006-06-16

Publications (1)

Publication Number Publication Date
ZA200808845B true ZA200808845B (en) 2009-10-28

Family

ID=38834237

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200808845A ZA200808845B (en) 2006-06-16 2008-10-16 Novel DNA sequences, vectors and proteins of Avian Influenza hemagglutinin

Country Status (11)

Country Link
US (1) US8163876B2 (fr)
EP (1) EP2029167A4 (fr)
JP (1) JP2009540801A (fr)
KR (1) KR20090027216A (fr)
CN (1) CN101472607A (fr)
AR (1) AR061484A1 (fr)
AU (1) AU2007261196A1 (fr)
BR (1) BRPI0713671A2 (fr)
CA (1) CA2654178A1 (fr)
WO (1) WO2007149715A2 (fr)
ZA (1) ZA200808845B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2526720C (fr) 2003-05-22 2013-10-22 Fraunhofer Usa, Inc. Molecule support recombinee pour l'expression, l'administration et la purification de polypeptides cibles
EP1919504B1 (fr) 2005-08-03 2013-10-16 iBio, Inc. Anticorps diriges contre l'antigene protecteur de bacillus anthracis
JP2009540801A (ja) * 2006-06-16 2009-11-26 ダウ・アグロサイエンス・エル・エル・シー トリインフルエンザ赤血球凝集素の新規なｄｎａ配列、ベクターおよびタンパク質
US8050871B2 (en) 2006-10-24 2011-11-01 Samuel Bogoch Method of predicting influenza outbreaks by correlating an increase in replikin count in shrimp white spot syndrome virus and/or taura syndrome virus
AU2008266702A1 (en) 2007-05-30 2008-12-24 Elenore S. Bogoch Synthetic replikin peptides against pathogenic infection of invertebrates in aquaculture
CA2692933C (fr) 2007-07-11 2016-10-18 Fraunhofer Usa, Inc. Antigenes yersinia pestis, compositions de vaccins, et methodes associees
WO2009132209A2 (fr) * 2008-04-23 2009-10-29 Samuel Bogoch Procédés et composés pour atténuer les flambées pathogènes au moyen des cycles de la réplikine
CN102165062B (zh) * 2008-07-18 2017-09-08 麦迪卡格公司 新的流感病毒免疫表位
US20120034253A1 (en) * 2008-09-25 2012-02-09 Fraunhofer Usa, Inc. Influenza Vaccines, Antigens, Compositions, and Methods
US8734803B2 (en) 2008-09-28 2014-05-27 Ibio Inc. Humanized neuraminidase antibody and methods of use thereof
US9233148B2 (en) 2009-01-09 2016-01-12 Samuel Bogoch Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza
CA2759325A1 (fr) * 2009-04-23 2010-10-28 Samuel Bogoch Sequences de replikine pour la prevention/le traitement de la grippe et la determination de l'infectiosite/la letalite
US9320784B2 (en) 2009-08-07 2016-04-26 Samuel Bogoch Peptides shared among lethal cancers and therapeutic compositions comprising said peptides
WO2011041391A1 (fr) 2009-09-29 2011-04-07 Fraunhofer Usa, Inc. Anticorps dirigés contre l'hémagglutinine du virus de la grippe, compositions, et procédés associés
CN101693894B (zh) * 2009-10-15 2011-07-27 北京大学深圳研究生院 禽流感病毒h5n1假病毒及其制备方法与专用dna片段
AR083533A1 (es) * 2010-10-22 2013-03-06 Boehringer Ingelheim Vetmed Proteinas de hemaglutinina 5 (h5) para el tratamiento y prevencion de las infecciones de gripe
JP6248040B2 (ja) * 2011-09-30 2017-12-13 メディカゴ インコーポレイテッド 植物における増加するウイルス様粒子収量
US9969794B2 (en) 2012-05-10 2018-05-15 Visterra, Inc. HA binding agents
RU2531235C2 (ru) 2013-02-15 2014-10-20 Общество с ограниченной ответственностью "Универсальные БиоСистемы" (ООО "УБС") Поливалентная вакцина против гриппа на основе гибридного белка
WO2015048129A1 (fr) * 2013-09-24 2015-04-02 CHOI, Duk, Kyung Polypeptides du virus de la grippe aviaire et leurs méthodes d'utilisation
WO2017083627A1 (fr) 2015-11-13 2017-05-18 Visterra, Inc. Compositions et méthodes pour traiter et prévenir la grippe
GB2578163A (en) * 2018-10-19 2020-04-22 Univ Pretoria Plant produced avian influenza antigens and their uses in diagnostic assays and devices
CN113924147A (zh) 2019-03-25 2022-01-11 威特拉公司 用于治疗和预防流感的组合物和方法
WO2022198085A2 (fr) * 2021-03-18 2022-09-22 Calyxt, Inc. Matrices de cellules végétales et leurs procédés
CN118076389A (zh) * 2021-08-30 2024-05-24 日环科学株式会社 免疫赋活制剂及含有该免疫赋活制剂的化妆品、食品、饲料添加剂、准药品

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004235813B2 (en) 2003-05-05 2010-07-29 Boyce Thompson Institute For Plant Research Vectors and cells for preparing immunoprotective compositions derived from transgenic plants
AU2005248377B2 (en) * 2004-05-25 2011-03-24 Medimmune, Llc Influenza hemagglutinin and neuraminidase variants
BRPI0710689A2 (pt) 2006-04-21 2012-02-22 Dow Agrosciences Llc método para preparação de uma vacina de aiv feita de planta e a referida vacina
JP2009540801A (ja) * 2006-06-16 2009-11-26 ダウ・アグロサイエンス・エル・エル・シー トリインフルエンザ赤血球凝集素の新規なｄｎａ配列、ベクターおよびタンパク質

Also Published As

Publication number Publication date
WO2007149715A2 (fr) 2007-12-27
JP2009540801A (ja) 2009-11-26
AU2007261196A1 (en) 2007-12-27
EP2029167A2 (fr) 2009-03-04
CA2654178A1 (fr) 2007-12-27
BRPI0713671A2 (pt) 2013-12-03
EP2029167A4 (fr) 2010-06-16
KR20090027216A (ko) 2009-03-16
US20090106864A1 (en) 2009-04-23
WO2007149715A3 (fr) 2008-07-24
AR061484A1 (es) 2008-08-27
US8163876B2 (en) 2012-04-24
CN101472607A (zh) 2009-07-01

Similar Documents

Publication Publication Date Title
ZA200808845B (en) Novel DNA sequences, vectors and proteins of Avian Influenza hemagglutinin
HUE049580T2 (hu) Hemagglutinint és mátrixfehérjéket tartalmazó, influenza elleni oltóanyagok
EP1851238A4 (fr) Acides nucleiques d'influenza, polypeptides et leurs utilisations
FI20060946A0 (fi) Influenssaviruksen nukleiinihappoja ja peptidejä
BRPI1008018A2 (pt) ácidos nucleicos de adenovírus símio e sequências de aminoácidos, vetores contendo os mesmos e uso dos mesmos
EP2037737A4 (fr) Protéines, acides nucléiques encodant celles-ci et leurs procédés d'utilisation associés
WO2008021959A3 (fr) Variants d'hémagglutinine et de neuraminidase de la grippe
HUE039950T2 (hu) Fehérjeexpresszió több nukleinsavból
MX2011000437A (es) Variantes de hemaglutinina y neuramnidasa de influenza.
IL213189A0 (en) Recombinant avian influenza vaccine and uses thereof
EP2010210A4 (fr) Vaccin contre la grippe aviaire et procedes d'utilisation
EP2086576A4 (fr) Nouvellles protéines h5, molécules d'acide nucléique, leurs vecteurs codants et leur utilisation médicale
EP1989316A4 (fr) Méthode de production de virus recombinant, de constructions d'adn et de compositions de vaccin
EP1973945A4 (fr) Nouvelles séquences de nucléotides et d'acides aminés et leurs procédés d'utilisation pour le diagnostic
EP1871786A4 (fr) Vaccin peptidique contre la grippe
IL213749A0 (en) Dgati nucleic acids and proteins and methods of use thereof
FI20080333A0 (fi) Influenssaviruksen nukleiinihappoja ja peptidejä
ZA200807553B (en) Recombinant newcastle disease virus expressing H5 Hemagglutinin of avian influenza virus
EP2238146A4 (fr) Polypeptides d'hémagglutinine, réactifs, et procédés s'y rapportant
ZA201200046B (en) Therapeutic peptides, polypeptides and nucleic acid sequences
IL193840A0 (en) Intranasal influenza vaccine based on virosomes
EP2320931A4 (fr) Compositions comprenant des acides nucléiques mg29, polypeptides et procédés associés d utilisation
ZA200902023B (en) Novel H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
HK1128077A1 (en) Intranasal influenza vaccine based on virosomes
IL174465A0 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis